OBINUTUZUMAB (GAZYVA), A POTENT ANTI-B CELL AGENT, IN THE TREATMENT OF RITUXIMAB-UNRESPONSIVE IGM ANTI-MYELIN-ASSOCIATEDGLYCOPROTEIN (MAG)-MEDIATED-NEUROPATHY

Rakocevic, G; Martinez-Outschoorn, U; Dalakas, M

MUSCLE & NERVE, 2018; 58 (): S88

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索